Kaempferol 3-O-β-D-galactoside is a flavonol glycoside frequently studied in biochemical research for its biological activity. While kaempferol is a common aglycone, the attachment of a galactose moiety at the C-3 position modifies the molecule's physical and biological characteristics. This modification increases the compound's solubility and influences its interaction with cellular transporters in laboratory models. Kaempferol 3-O-β-D-galactoside is a high-value flavonoid glycoside with significant applications in the pharmaceutical, nutraceutical, and cosmetic industries. Unlike traditional plant extraction, which often suffers from low yields and complex purification needs. Creative Biolabs' custom production service utilizes Advanced Enzymatic Synthesis to help you obtain high-quality, bioactive flavonol glycosides and streamline your metabolic studies through our recombinant Glycosyltransferases (GTs) platform and biocatalytic engineering techniques.

Fig.1 Antiviral mechanism of kaempferol derivatives. (OA Literature) Fig.1 The antiviral mechanisms of kaempferol and its derivatives.¹

By employing Kaempferol 3-O-Galactosyltransferase as a precise biocatalyst, we offer a scalable, sustainable, and high-purity solution for your research and industrial requirements. Our production platform is centered on a biotransformation approach. This method leverages the high regioselectivity of GTs to attach a galactose moiety specifically to the C-3 position of the kaempferol aglycone.

Substrate: Kaempferol (high-purity aglycone).
Enzyme Catalyst: Recombinant kaempferol 3-O-galactosyltransferase.
Sugar Donor: UDP-Galactose (Uridine diphosphate galactose).

By focusing on an enzymatic route, we eliminate the formation of unwanted isomers and minimize the environmental impact associated with harsh chemical synthesis.

Fig.2 Structures of common kaempferol derivatives. (OA Literature) Fig.2 Kaempferol and its common derivatives.¹

Characterization of the Biocatalyst

The core of our service is the specialized kaempferol 3-O-Galactosyltransferase. This enzyme is typically sourced from plant species known for high trifolin content and is expressed in optimized microbial hosts (e.g., Escherichia coli or Pichia pastoris).

01Regiospecificity

The enzyme is engineered to target only the 3-OH group, ensuring the production of the β-D-galactoside linkage rather than other glycosidic forms.

02Kinetics

We utilize enzyme variants with high affinity for kaempferol and high turnover rates, ensuring efficient conversion even at high substrate concentrations.

03Stability

Our enzymes are stabilized through immobilization or buffer optimization to maintain activity throughout the production cycle.

Find Your Perfect Solution - Inquire Now

The Detailed Production Process

The production workflow is divided into four critical stages, ensuring that the final product meets the highest standards of purity and biological activity.

I. Selection of Starting Materials

We select high-purity kaempferol 3-O-galactosyltransferase as the biocatalyst. Activity is measured for each batch of enzyme to standardize the "units per milliliter," ensuring reproducible reaction kinetics for every custom order. Kaempferol is naturally hydrophobic. To facilitate the enzymatic reaction, we employ co-solvents or cyclodextrin encapsulation to increase the bioavailability of the substrate in the aqueous reaction environment. The reaction buffer is optimized for pH and temperature to maximize enzyme longevity.

II. Controlled Biocatalytic Reaction

The reaction is conducted in a stirred-tank bioreactor. We utilize a "Fed-Batch" strategy for the sugar donor, UDP-Galactose, to prevent substrate inhibition and maintain a steady reaction rate.

III. Downstream Purification

Once the conversion of kaempferol to kaempferol 3-O-β-D-galactoside is complete (monitored via HPLC), the mixture is filtered to remove the enzyme. The glycoside is captured using macroporous resins or preparative HPLC. This step separates the product from unreacted aglycone and byproducts.

IV. Crystallization and Lyophilization

The purified fraction is concentrated under vacuum. To ensure long-term stability, the product is crystallized or lyophilized into powder.

Professional Kaempferol 3-O-β-D-Galactoside production solutions. (Creative Biolabs AI)

Comprehensive Service Features

High Regioselectivity and Isomeric Purity: Our service guarantees 100% regioselectivity at the C-3 position. By using specific galactosyltransferases, we ensure that no kaempferol 7-O-galactoside or other isomers are produced, which is critical for bioactive consistency in pharmaceutical applications.
Scalable Production Capacity: Whether you require milligram quantities for preliminary screening or kilogram-scale batches for projects, our infrastructure is designed to scale. Our bioreactors range from 1L to 500L, allowing us to maintain the same enzymatic parameters across different volumes, ensuring that the product quality remains identical as your project grows.
Customized Formulation and Stabilization: We recognize that different applications require different formats. Our service includes options for custom formulation, such as micronization for improved solubility, or the provision of the product in specific buffer concentrates or stabilized solutions, ready for immediate use in your workflows.

Application

Drug development: Kaempferol 3-O-β-D-galactoside possesses significant anti-inflammatory activity. It inhibits the expression of pro-inflammatory cytokines (such as TNF-α and IL-6) and is used in research for the prevention and treatment of chronic inflammatory diseases, arthritis, and respiratory inflammation.
Skincare products: As a powerful free radical scavenger, this ingredient protects skin cells from UV-induced oxidative damage. In the cosmetics industry, it is often used as a core active ingredient in high-end anti-aging serums or sunscreen repair products, reducing collagen degradation.
Food additives: Due to its natural origin and bioactivity, it is used as a fortifier in functional foods. It is used to develop health drinks with immunomodulatory and anti-fatigue functions, leveraging its biopharmaceutical properties to enhance product added value.

Find Your Perfect Solution - Get a Quote Now

FAQs

Q1: How does Creative Biolabs ensure the specific placement of the galactose moiety?

A1: Our production relies on a specialized recombinant kaempferol 3-O-galactosyltransferase. This enzymatic catalyst inherently recognizes only the C-3 position, ensuring specific placement without the need for complex chemical shielding often used in traditional synthesis.

Q2: What is the difference between kaempferol 3-O-galactoside and other glycosides?

A2: While similar to other glycosides, the galactose moiety can lead to different experimental observations in metabolic pathways compared to glucose or rhamnose attachments. Our custom service allows you to isolate these effects using pure standards.

Q3: What analysis methods are used for quality verification?

A3: Every batch undergoes characterization using NMR spectroscopy and mass spectrometry. We focus on the coupling constants and molecular mass to confirm the structure and anomeric configuration.

Q4: How should the purified galactoside be stored in the lab?

A4: We recommend storing the lyophilized powder at -20 °C in a dry environment. This helps maintain the stability of the compound for extended research periods.

Customer Review

Precision Regioselectivity in Laboratory Assays
"Using Creative Biolabs' custom kaempferol 3-O-β-D-galactoside production service has been helpful for our metabolic signaling research. In previous experiments using other analogs, we struggled with trace isomers that skewed our results. Creative Biolabs' platform provided a 100% regioselective 3-O-linkage."- Dr. A**lc.

Consistency for Analytical Screening
"In our laboratory profiling, consistency is important. We have used Creative Biolabs' production service because their purified product consistently meets high HPLC purity standards. This has reduced our baseline noise in oxidative response assays."- Prof. E**na.

Enhanced Bioavailability Studies
"Our laboratory investigates the comparative characteristics of flavonoid glucosides versus galactosides. Using Creative Biolabs' production service, we were able to obtain high volumes of kaempferol 3-O-β-D-galactoside for our research models. The purity enabled clear differentiation in experimental absorption rates."- Dr. Li W***

Extended Services

Custom Glycosylation

Beyond galactosylation, we provide precision glycosylation services for various flavonols. This includes the production of 3-O-glucoside and 7-O-glucoside derivatives using specific glucosyltransferases. This service is ideal for comparative studies where researchers need to evaluate the metabolic differences between glucose and galactose attachments on the same aglycone scaffold.

Enzyme Engineering and Development

We provide custom enzyme engineering for research projects requiring specific enzymatic properties. Utilizing directed evolution and rational design techniques, we tailor our biocatalysts to meet the rigorous demands of your specialized laboratory processes.

High-Resolution Metabolic Analysis

To complement our production services, we offer advanced analytical services for quantifying and identifying flavonoid metabolites in complex research samples. Using high-resolution LC-MS/MS and specialized extraction protocols, we provide detailed metabolic profiles that help researchers track the behavior of glycosides in various biological models.

How to Contact Us

By combining the precision of nature's catalysts with modern bioprocess engineering, Creative Biolabs' custom kaempferol 3-O-β-D-galactoside production service provides a reliable, high-quality source of this essential flavonoid. We are committed to supporting your research and development through technical excellence and tailored production strategies. For project discussions or to receive a custom quote, please reach out to our technical team.

Reference

Periferakis, Argyrios et al. "Kaempferol: A Review of Current Evidence of Its Antiviral Potential." International Journal of Molecular Sciences vol. 24,22 16299. 14 Nov. 2023. Distributed under an Open Access license CC BY 4.0, without modification. https://doi.org/10.3390/ijms242216299

For Research Use Only.

Related Services

Online Inquiry